IPOPLUS

532.2

-12.75 -2.34%

18 Jun 2026

NSE Listed

Panacea Biotec Limited (PANACEABIO)

Volume: 95,942Avg Vol 1W: 1,92,323.8Avg Vol 1M: 1,61,581.0552W Range:292.4647
₹532.2 2.34%
Key Ratios
Updated 5h ago
Market Cap₹3,291 Cr
Current Price₹532.2
Previous Close₹544.95
High / Low (52w)₹647 / ₹292.4
Volume95,942
Avg Vol (1W)1,92,323.8
Avg Vol (1M)1,61,581.05
Stock P/E4,784.38
Book Value₹136.19
Dividend Yield0%
ROE-2.9%
ROA-0.6%
Revenue (TTM)₹580 Cr
Revenue Growth0%
Profit Margin-0.8%
Total Debt₹15 Cr
Shares Outstanding6 Cr
Face Value₹1
EPS (TTM)₹0.08
P/B3.94
Debt / Equity0.03
50 DMA₹342.47
200 DMA₹382.5
Day change-2.34%
Price Chart
532.2 22.12% · 1Y
5322972.4Cr
2025-06-17
2026-05-11

20-day avg volume: 1.6L shares

Pros
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 4784.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹116 Cr₹147 Cr₹163 Cr₹133 Cr₹167 Cr₹141 Cr₹165 Cr₹167 Cr
EBITDA₹-19 Cr₹3 Cr₹3 Cr₹-27 Cr₹-4 Cr₹-20 Cr₹6 Cr₹-3 Cr
Net Profit₹-16 Cr₹5 Cr₹5 Cr₹-2 Cr₹4 Cr₹-14 Cr₹4 Cr₹1 Cr
EPS
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹574 Cr₹635 Cr₹672 Cr₹512 Cr₹585 Cr₹580 Cr
EBITDA₹18 Cr₹41 Cr₹-46 Cr₹-85 Cr₹-31 Cr₹-40 Cr
Net Profit₹-194 Cr₹-148 Cr₹1,078 Cr₹-33 Cr₹-1 Cr₹-8 Cr
EPS
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹1,390 Cr₹1,178 Cr₹1,759 Cr₹1,271 Cr₹1,241 Cr₹1,290 Cr
Total Liabilities₹1,195 Cr₹1,409 Cr₹885 Cr₹431 Cr₹402 Cr₹459 Cr
Equity₹196 Cr₹-232 Cr₹874 Cr₹840 Cr₹838 Cr₹831 Cr
Total Debt₹610 Cr₹732 Cr₹30 Cr₹15 Cr₹15 Cr₹15 Cr
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-22 Cr₹108 Cr₹295 Cr₹-420 Cr₹2 Cr₹-26 Cr
Investing₹-35 Cr₹-48 Cr₹1,283 Cr₹430 Cr₹10 Cr₹65 Cr
Financing₹91 Cr₹-47 Cr₹-1,176 Cr₹-18 Cr₹-3 Cr₹-3 Cr
Free Cash Flow₹-22 Cr₹108 Cr₹295 Cr₹-420 Cr₹2 Cr₹-26 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search